Kestra Medical Technologies Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Kestra Medical Technologies, Ltd. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2021FY 2020
Period EndingApr 2025Dec 2024Apr 2023Apr 2021Apr 2020
Revenue & Gross Profit
Revenue59.8259.827.630.000.00
Cost of Revenue35.6135.6118.280.000.00
Gross Profit24.2124.21-10.650.000.00
Operating Expenses
Research & Development15.6515.6515.7618.8122.80
Selling, General & Administrative114.94114.9454.0113.906.52
Operating Expenses130.59130.5969.7732.7129.32
Operating Income-106.38-106.38-80.42-32.71-29.32
Other Income/Expense
Interest Income3.203.200.000.000.00
Interest Expense-7.737.73-5.63-1.170.00
Other Income/Expense-2.77-7.301.83-0.040.00
Income
Income Before Tax-113.68-113.68-84.22-33.91-29.32
Income Tax Expense0.140.140.020.190.15
Net Income-113.81-113.81-84.24-34.10-29.47
Net Income - Continuous Operations-113.81-113.81-84.24-34.100.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-98.41-97.98-75.57-32.29-28.84
EBIT-106.38-85.06-80.42-32.71-29.32
Depreciation & Amortization7.977.974.860.420.48
Earnings Per Share
Basic EPS-5.00-5.00-820.00-322.00-278.00
Diluted EPS-5.00-5.00-820.00-322.00-278.00
Basic Shares Outstanding24.5849.530.110.110.11
Diluted Shares Outstanding24.5849.530.110.110.11